company background image
OKYO logo

OKYO Pharma LSE:OKYO Lagerbericht

Letzter Preis

UK£0.91

Marktkapitalisierung

UK£23.2m

7D

-31.7%

1Y

-63.6%

Aktualisiert

22 May, 2023

Daten

Finanzdaten des Unternehmens +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

OKYO Aktienübersicht

A clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.

OKYO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

OKYO Pharma Limited Wettbewerber

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for OKYO Pharma
Historical stock prices
Current Share PriceUK£0.91
52 Week HighUK£3.90
52 Week LowUK£0.88
Beta-0.062
1 Month Change-9.68%
3 Month Change-65.69%
1 Year Change-63.64%
3 Year Change-45.10%
5 Year Changen/a
Change since IPO-98.13%

Aktuelle Nachrichten und Updates

Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Nov 26
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Recent updates

Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Nov 26
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Jan 27
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

Sep 22
Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

Mar 17
We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Dec 02
We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Aktionärsrenditen

OKYOGB BiotechsGB Markt
7D-31.7%-3.4%-1.4%
1Y-63.6%-28.0%4.4%

Rendite im Vergleich zur Industrie: OKYO underperformed the UK Biotechs industry which returned -16.5% over the past year.

Rendite vs. Markt: OKYO underperformed the UK Market which returned -2.2% over the past year.

Preisvolatilität

Is OKYO's price volatile compared to industry and market?
OKYO volatility
OKYO Average Weekly Movement18.1%
Biotechs Industry Average Movement6.1%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.8%

Stabiler Aktienkurs: OKYO's share price has been volatile over the past 3 months.

Volatilität im Zeitverlauf: OKYO's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of UK stocks.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
20077Gary Jacobwww.okyopharma.com

OKYO Pharma Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von OKYO Pharma im Vergleich zum Marktanteil des Unternehmens?
OKYO grundlegende Statistiken
MarktanteilUK£23.22m
Gewinn(TTM)-UK£6.70m
Umsatz(TTM)n/a

0.0x

Kurs-Umsatz-Verhältnis

-3.5x

Kurs-Gewinn-Verhältnis

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
OKYO Gewinn- und Verlustrechnung (TTM)
EinnahmenUK£0
Kosten der EinnahmenUK£4.39m
Bruttogewinn-UK£4.39m
Sonstige AusgabenUK£2.31m
Umsatz-UK£6.70m

Zuletzt gemeldete Gewinne

Sep 30, 2022

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)-0.26
Bruttomarge0.00%
Nettogewinnspanne0.00%
Schulden/Eigenkapital-Verhältnis0%

Wie hat sich OKYO auf lange Sicht entwickelt?

Historische Performance und Vergleiche